首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer journal

缩写:CANCER J

ISSN:1528-9117

e-ISSN:1540-336X

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1155
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Rifaquat Rahman,Minesh Mehta Rifaquat Rahman
The management of brain metastases is increasingly complex and requires multidisciplinary input from a wide array of experts, including radiation oncology, medical oncology, neurosurgery, and palliative care. Novel radiation techniques, rad...
Nicole Hajdari,David M Peereboom Nicole Hajdari
Brain metastases are a common yet dismal complication of metastatic cancers, originating most commonly from nonsmall cell lung cancer, breast cancer, melanoma, and renal cell carcinoma. While the current standard of care for most patients i...
Adannia Ufondu,Jana Haroun,Samuel Chao et al. Adannia Ufondu et al.
Radiation necrosis (RN) is a serious complication of stereotactic radiosurgery (SRS), affecting ∼5% to 25% of patients treated for brain metastases. Because RN is a late effect of radiation therapy with a typical onset of 6 to 12 months af...
Alexander Podgorsak,John Kang,Dandan Zheng et al. Alexander Podgorsak et al.
As the radiotherapeutic management of brain metastases increasingly utilizes stereotactic radiosurgery (SRS) and repeated treatments, artificial intelligence (AI) applications are being investigated in treatment planning, prognostication, a...
Brittney Chau,Eric Lin Chang,Adam Garsa Brittney Chau
Brain metastases affect up to 30% of cancer patients and can cause significant neurological effects. Treatment of brain metastases requires a multidisciplinary approach with surgery, radiation modalities, and systemic therapy all playing a ...
Hang Yu,Hany Soliman,Kang Liang Zeng et al. Hang Yu et al.
Optimal management of patients with brain metastases relies on both accurate detection on initial imaging and accurate differentiation between treatment-related effects from progression on follow-up imaging. Contrast-enhanced MRI remains th...
Praveen Pendyala,Adannia Ufondu,Vinai Gondi Praveen Pendyala
Whole brain radiation therapy (WBRT) continues to play a critical role in managing patients with extensive brain metastases, but neurocognitive decline remains a significant limitation. This review examines the clinical presentation and und...
Alexander Becker,Alejandro Carrasquilla,Michael A Vogelbaum Alexander Becker
Surgical resection is an important treatment consideration for patients with brain metastases, as it offers rapid symptom relief and enhances local control. Although surgery remains a mainstay of treatment, there exists increasing nuance in...
Ozum Atasoy,Eyub Y Akdemir,Rupesh Kotecha Ozum Atasoy
Brain metastases affect up to 40% of patients with cancer and represent a major clinical challenge. Despite advances in surgery, radiotherapy, and systemic therapies, outcomes remain modest, partly due to the blood-brain barrier and the lim...